Clinical Report: Privacy-Conscious Skin Cancer Diagnosis through Federated Learning
Overview
Expand on the comparison with traditional methods and define 'superior performance'.
Background
Skin cancer is a prevalent global health issue, with millions of new cases diagnosed annually, necessitating accurate and timely diagnostic measures. Traditional diagnostic methods face challenges such as inter-observer variability and limited access to dermatological expertise. The integration of artificial intelligence and machine learning offers promising advancements in improving diagnostic accuracy and patient outcomes.
Data Highlights
Model
Accuracy
F1-score
Confidence Interval
MobileNetV2 (Ring-based FL)
98.88%
98.80%
97.92–99.84%
Centralized Baseline
Not specified
Not specified
p < 0.01
Key Findings
MobileNetV2 with ring-based federated learning achieved an accuracy of 98.88%.
The framework demonstrated significant improvements over centralized methods (p < 0.01).
Higher convergence rates and reduced communication overhead were observed with MobileNetV2 compared to VGG16.
The performance degradation with increasing non-IID severity was gradual, indicating robustness.
The proposed framework complies with privacy regulations while maintaining high diagnostic utility.
Clinical Implications
The findings suggest that federated learning can effectively enhance skin cancer diagnosis while safeguarding patient privacy. Clinicians may consider adopting AI-assisted diagnostic tools that utilize federated learning to improve accuracy and efficiency in diverse healthcare settings.
Conclusion
Federated learning presents a viable solution for privacy-conscious skin cancer diagnosis, demonstrating that high diagnostic performance can be achieved without compromising patient confidentiality. This approach may facilitate broader implementation of AI in dermatology.
